35418-49-6 Usage
Chemical class
Indole derivatives
Bicyclic compound with a cyclopentane ring fused to an indole ring and a carboxylic acid group
Structure
Bicyclic ring system
Consists of a five-membered cyclopentane ring and a six-membered indole ring
Functional group
Carboxylic acid
Contains a carboxyl group (-COOH) that imparts acidic properties
Potential pharmacological properties
Therapeutic applications
Investigated for its possible use in medicinal chemistry and drug development
Biological activities
Diverse effects
Potential anti-inflammatory, antioxidant, and neuroprotective effects
Synthesis
New drug molecules
Structure and properties make it a promising candidate for the synthesis of new drug molecules with various biological activities
Further research
Exploration of potential uses and mechanisms of action
Requires additional studies to fully understand the potential applications and therapeutic effects of 1,2,3,4-tetrahydro-cyclopenta[b]indole-2-carboxylic acid
Check Digit Verification of cas no
The CAS Registry Mumber 35418-49-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,4,1 and 8 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 35418-49:
(7*3)+(6*5)+(5*4)+(4*1)+(3*8)+(2*4)+(1*9)=116
116 % 10 = 6
So 35418-49-6 is a valid CAS Registry Number.
35418-49-6Relevant articles and documents
-
Lacoume et al.
, p. 667,668, 669, 673 (1972)
-
TRICYCLIC CYTOPROTECTIVE COMPOUNDS
-
Page/Page column 15-16, (2008/06/13)
Compounds of formula (I): in which: X is a group of formula >CR1R2 or >SO2; Y is a group of formula >NH or >CR1R2; Z is a group of formula >C=O or >CH2 or a direct bond; R1 hydrogen and R2 is hydrogen, carboxy or hydroxy; or R1 and R2 together represent an oxo group, a methylenedioxy group or a hydroxyimino group; R3 is hydrogen or lower alkyl; R4 represents two hydrogen atoms, or an oxo or hydroxyimino group; R5 is hydrogen, lower alkyl or halogen; R6 is hydrogen, lower alkoxy or carboxy; R7 and R8 are each hydrogen, lower alkyl or halogen; and pharmaceutically acceptable salts and esters thereof can be used for the treatment or prophylaxis of acute or chronic neurodegenerative diseases or conditions such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Chorea, Multiple Sclerosis or the sequelae to acute ischaemic events such as heart attack, stroke or head injury and for protection against ischaemic damage to tissues of peripheral organs.
